Sperm DNA fragmentation and embryo aneuploidy: a comprehensive systematic review and meta-analysis
Reproductive BioMedicine Online · 2026-07 · 53 (1) · 105639
DOI: 10.1016/j.rbmo.2026.105639 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reproductive BioMedicine Online, 2026-07. Verfasst von Min Zou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Malaysia.; Huazh…. Hauptthemen laut MEDLINE: DNA Fragmentation, Aneuploidy, Spermatozoa, Reproductive Techniques, Assisted. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
RESEARCH QUESTION: What is the association between an elevated sperm DNA fragmentation index (DFI) and the risk of embryonic aneuploidy in couples undergoing assisted reproductive technology (ART) treatment? DESIGN: This PROSPERO-registered systematic review and meta-analysis (CRD420251067930) searched PubMed, Embase, Cochrane Library and Web of Science from inception to 10 July 2025 for observational studies. Studies were included if they reported on couples undergoing ART treatment with sperm DFI testing and preimplantation genetic testing. Heterogeneity was explored via pre-specified subgroup analyses. Robustness was evaluated through sensitivity analyses (leave-one-out method) and assessment of publication bias using funnel plots and Egger's test. RESULTS: From 601 records, 11 studies were systematically reviewed. Meta-analysis of seven studies (3563 embryos) revealed a significant, albeit modest, positive association (pooled RR = 1.16, 95% CI 1.03 to 1.31), with considerable heterogeneity (I² = 55%). The significance of this association varied across subgroups. No significant publication bias was detected, and sensitivity analyses confirmed the robustness of the primary finding. CONCLUSIONS: Current evidence, derived solely from retrospective studies, establishes a modest link but is insufficient to recommend sperm DFI testing as an independent guide for clinical decisions, highlighting the need for prospective validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Malaysia.; Huazhong Reproductive Gynaecology Hospital of Wuhan, 128 Sanyang Road, Wuha…
- Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Malaysia.
- Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Malaysia.. Electronic address: mahanem@ukm.edu.my.
Zitieren
APA
Zou, M., Raffi, N. A., & Noor, M. M. (2026). Sperm DNA fragmentation and embryo aneuploidy: a comprehensive systematic review and meta-analysis. Reproductive BioMedicine Online, 53(1), 105639. https://doi.org/10.1016/j.rbmo.2026.105639
Vancouver
Zou M, Raffi NA, Noor MM. Sperm DNA fragmentation and embryo aneuploidy: a comprehensive systematic review and meta-analysis. Reproductive BioMedicine Online. 2026;53(1):105639. doi:10.1016/j.rbmo.2026.105639
BibTeX
@article{Zou2026,
author = {Zou, Min and Raffi, Nur Ab and Noor, Mahanem M},
title = {Sperm DNA fragmentation and embryo aneuploidy: a comprehensive systematic review and meta-analysis},
journal = {Reproductive BioMedicine Online},
year = {2026},
volume = {53},
number = {1},
pages = {105639},
doi = {10.1016/j.rbmo.2026.105639}
}
EUVIMED